Amneal Pharma: Leerink Partners raises target price to $25 from $23
AMRX•Leerink Partners raised its target price for Amneal Pharma to $25 from $23.
Related News
RBC raises Block target price to $103 from $95
XYZ•
Election flop leaves Donald Trump a wounded animal
SPY•
Williams Companies: Raymond James raises target price to $86 from $85
WMB•
First Bank (Hamilton): Piper Sandler raises target price to $23 from $20
FRBA•
Market analysts react to US midterm election results
SPY•